The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

Autor: King, Erin R., Zu, Zhifei, Tsang, Yvonne T.M., Deavers, Michael T., Malpica, Anais, Mok, Samuel C., Gershenson, David M., Wong, Kwong-Kwok
Zdroj: In Gynecologic Oncology 2011 123(1):13-18
Databáze: ScienceDirect